𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb

✍ Scribed by Oihana Murillo; Juan Dubrot; Asís Palazón; Ainhoa Arina; Arantza Azpilikueta; Carlos Alfaro; Sarai Solano; María C. Ochoa; Carmen Berasain; Izaskun Gabari; José. L. Pérez-Gracia; Pedro Berraondo; Sandra Hervás-Stubbs; Ignacio Melero


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
532 KB
Volume
39
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


CD8+Foxp3+ tumor infiltrating lymphocyte
✍ Dung T. Le; Brian H. Ladle; Timothy Lee; Vivian Weiss; Xiaosai Yao; Ashley Leubn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 674 KB

## Abstract The composition of tumor infiltrating lymphocytes (TIL) is heterogeneous. In addition, the ratio of various subpopulations in the tumor microenvironment is highly dependent on the nature of the host's immune response. Here, we characterize Foxp3‐expressing CD8^+^ T cells in the tumor th

Potentiation of the anti-tumor effect of
✍ Witold Lasek; Adam Giermasz; Katarzyna Kuc; Anna Wańkowicz; Wojciech Feleszko; J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 667 KB

The anti-tumor effects of actinomycin D (Act D) and recombinant human tumor necrosis factor (TNF)-a have been studied on 4 established murine tumor cell lines: MmBI6 melanoma, Lewis lung (LL/2) carcinoma, L I sarcoma and L I 2 10 leukemia. During short-term incubation (24 hr) Act D produced dosedepe

Vaccination of tumor cells transfected w
✍ Hideki Fujii; Manabu Inobe; Fuminari Kimura; Jun Murata; Masaaki Murakami; Yasuh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 766 KB

The present study demonstrates that the transfection of B7-I or its variant MB7-2 genes into MHC class I+ tumor cells (B 16-BL6 or K I 735-M2 melanoma) resulted in the remarkable reduction of lung metastasis caused by i.v. injection into immunocompetent syngeneic mice. However, i.v. injection of the

In vivo efficacy of the recombinant anti
✍ Mehmet Kemal Tur; Michael Huhn; Edgar Jost; Theo Thepen; Tim H. Brümmendorf; Ste 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 533 KB

## Abstract Target‐specific acute myeloid leukemia (AML) immunotherapy requires selective cell‐surface antigens on AML blast cells. CD64 is a promising candidate antigen because it is abundantly expressed on monocytoid differentiated AML subtypes. In previous studies, a chemically linked full‐lengt